Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong Kwang Min

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ACS Applied Materials & Interfaces|August 24, 2025
Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 ModulationDong Kwang Min, Xin Wang Mo, Jaeyun Kim
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 4, 2026
Recent advances in ROS-modulating materials for sepsis treatmentXin Wang Mo, Dong Kwang Min, Jaeyun Kim
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 21, 2026
Advanced engineering of hydrogel platforms for cancer immunotherapy via distinct administration routesXin Wang Mo, Dong Kwang Min, Jaeyun Kim
Biomaterials|December 11, 2024
Mesoporous polydopamine nanoparticle-based tolerogenic vaccine induces antigen-specific immune tolerance to prevent and treat autoimmune multiple sclerosisNgoc Man Phan, Thanh Loc Nguyen, Dong Kwang Min, et al.
ACS Nano|December 1, 2023
Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in ColitisDong Kwang Min, Ye Eun Kim, Min Kyung Kim, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 31, 2026
Safe and Localized Lentiviral Gene Delivery via Injectable Mesoporous Scaffolds for Potent Antitumor ImmunityThanh Loc Nguyen, Yeon-Ju Kim, Jihye Im, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ACS Applied Materials & Interfaces|August 24, 2025
Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 ModulationDong Kwang Min, Xin Wang Mo, Jaeyun Kim
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 4, 2026
Recent advances in ROS-modulating materials for sepsis treatmentXin Wang Mo, Dong Kwang Min, Jaeyun Kim
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 21, 2026
Advanced engineering of hydrogel platforms for cancer immunotherapy via distinct administration routesXin Wang Mo, Dong Kwang Min, Jaeyun Kim
Biomaterials|December 11, 2024
Mesoporous polydopamine nanoparticle-based tolerogenic vaccine induces antigen-specific immune tolerance to prevent and treat autoimmune multiple sclerosisNgoc Man Phan, Thanh Loc Nguyen, Dong Kwang Min, et al.
ACS Nano|December 1, 2023
Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in ColitisDong Kwang Min, Ye Eun Kim, Min Kyung Kim, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 31, 2026
Safe and Localized Lentiviral Gene Delivery via Injectable Mesoporous Scaffolds for Potent Antitumor ImmunityThanh Loc Nguyen, Yeon-Ju Kim, Jihye Im, et al.
Pageof 1